Business

ZLDs Diabetic Nerve Pain Drug Trial Two-Thirds Enrolled

ZLDs Diabetic Nerve Pain Drug Trial Two-Thirds Enrolled

Zelira Therapeutics Ltd.September 14, 20223
ZLDs Diabetic Nerve Pain Drug Trial Two-Thirds Enrolled

About this update from Zelira Therapeutics Ltd.

Zelira Therapeutics Ltd has released a press release. View Attachment

View stock analysis, news, and events for Zelira Therapeutics Ltd.

More from Zelira Therapeutics Ltd.

All Zelira Therapeutics Ltd. news →